We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Thyroid Hormone Levels Associated with Arterial Disease

By LabMedica International staff writers
Posted on 15 Nov 2017
Print article
Image: A range of Elecsys and cobas Reagents for thyroid function test kits (Photo courtesy of Roche).
Image: A range of Elecsys and cobas Reagents for thyroid function test kits (Photo courtesy of Roche).
Atherosclerosis is the process of progressive thickening and hardening of the walls of arteries from fat deposits on their inner lining. Atherosclerosis progresses insidiously from a subclinical condition to the clinical onset of vascular events to death.

High and high-normal levels of a thyroid hormone called free thyroxine 4 (FT4), are associated with artery disease and death in elderly and middle-aged people. FT4 is a hormone produced by the thyroid gland that helps control the rate at which the body uses energy.

Medical scientists at the Erasmus Medical Center (Rotterdam, The Netherlands) carried out a prospective population-based cohort study that investigated the determinants, occurrence and progression of chronic diseases in the middle-aged and elderly. Baseline measurements for the study were performed during the third visit of the first cohort of 4,797 and the first visit of the second of group of 3,011 and third cohort of 3,932 in the Rotterdam Study.

Thyroid function was assessed at baseline in three study cohorts using the same method and assay. Measurements of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and thyroid peroxidase antibodies (TPOAb) were performed in baseline serum samples stored at -80 °C using the electrochemiluminescence immunoassay ECLIA. The reference ranges of serum TSH (0.40–4.0 mIU/L) and serum FT4 (0.86–1.94 ng/dL; equivalent to 11–25 pmol/L) were determined.

The team found that after a median follow-up of 8.8 years, there were 612 atherosclerosis-related cardiovascular deaths and 934 first-time atherosclerosis-related cardiovascular events. Increasing FT4 levels were associated with twice the odds of having high levels of coronary artery calcification scores, which may be an indicator of subclinical atherosclerosis; 87% greater risk of suffering an atherosclerosis-related cardiovascular event; and double the risk of atherosclerosis-related cardiovascular death. The authors conclude that FT4 levels in middle-aged and elderly subjects were positively associated with atherosclerosis throughout the whole disease spectrum, independently of cardiovascular risk factors.

Arjola Bano, MD, MSc, DSc, the lead study author, said, “We expected that thyroid function would influence the risk of developing atherosclerosis by affecting cardiovascular risk factors such as blood pressure. However, our results remained very similar after accounting for several cardiovascular risk factors. This suggests that mechanisms other than traditional cardiovascular risk factors may play a role. Our findings suggest that thyroid hormone FT4 measurement can help identify individuals at increased risk of atherosclerosis.” The study was published on October 31, 2017, in the journal Circulation Research.

Related Links:
Erasmus Medical Center

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.